Advertisement

Current Diabetes Reports

, 14:444 | Cite as

Diabetes and Hyperglycemia in the Critical Care Setting: Has the Evidence for Glycemic Control Vanished? (Or … Is Going Away?)

  • Amy E. Wagstaff
  • N. Wah CheungEmail author
Hospital Management of Diabetes (G Umpierrez, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Hospital Management of Diabetes

Abstract

Hyperglycemia is associated with increased mortality and other complications amongst hospitalized patients. However, the studies of tight glycemic control in a range of critical illness settings, including intensive care, acute myocardial infarction, and stroke, have produced inconsistent and divergent results. We examine some of the factors that may have contributed to the differing results, and their implications for targeting tight glucose control in critical illness. With these in mind, most clinical guidelines now recommend moderate glucose control with an upper glucose target of <10 mmol/L (180 mg/dL) in critical illness while avoiding hypoglycemia.

Keywords

Hyperglycemia Diabetes Glucose Critical illness Hospital Intensive care Glycemic control Critical care setting 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

A.E. Wagstaff declares that she has no conflict of interest. N.W. Cheung declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article contains studies with human subjects performed by Dr. NW Cheung, who was a chief investigator in the HI-5 and QASC studies, both of which are human studies referred to in this paper. Both studies were approved by Ethics committees and informed consent was obtained from all participants in these studies.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Finney SJ, Zekfeld C, Elia A, Evans TW. Glucose control and mortality in critical illness. JAMA. 2003;290:2041–4.PubMedCrossRefGoogle Scholar
  2. 2.
    Bagshaw SM, Egi M, George C, Bellomo R. The ANZICS Database Management Committee: early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009;37:463–70.PubMedCrossRefGoogle Scholar
  3. 3.
    Wong V, Ross DL, Park K, Boyages S, Cheung NW. Hyperglycemia following acute myocardial infarction is a predictor of poor cardiac outcomes in the reperfusion era. Diab Res Clin Pract. 2004;64:85–91.7.CrossRefGoogle Scholar
  4. 4.
    Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Circulation. 2005;111:3078–86.PubMedCrossRefGoogle Scholar
  5. 5.
    Goyal A, Mehta SR, Diaz R, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation. 2009;120:2429–37.PubMedCrossRefGoogle Scholar
  6. 6.
    Timmer JR, Hoekstra M, Nijsten MWN, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Circulation. 2011;124:704–11.PubMedCrossRefGoogle Scholar
  7. 7.
    Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II Trial. Stroke. 2008;39:2749–55.PubMedCrossRefGoogle Scholar
  8. 8.
    Poppe AY, Majumdar SR, Jeerakathil T, et al. Admission hyperglycaemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care. 2009;32:617–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058–62.PubMedCrossRefGoogle Scholar
  10. 10.
    Zerr KJ, Furnary AP, Grunkemeier GL, et al. Infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356–61.PubMedCrossRefGoogle Scholar
  11. 11.
    Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28:2367–71.PubMedCrossRefGoogle Scholar
  12. 12.
    Cheung NW, Ma G, Li S, Crampton R. The relationship between admission blood glucose levels and hospital mortality. Diabetologia. 2008;51:952–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.PubMedGoogle Scholar
  14. 14.
    Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798–07.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971;284:621–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Bagdade J, Neilson K, Bulger R. Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci. 1972;263:451–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Nielson C, Hindson D. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentration in vitro. Diabetes. 1989;38:1031–5.PubMedCrossRefGoogle Scholar
  18. 18.
    McManus LM, Bloodworth RC, Prihoda TJ, et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol. 2001;70:395–404.PubMedGoogle Scholar
  19. 19.
    Von Kanel R, Mills P, Dimsdale J. Short term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. Life Sci. 2001;69:255–62.CrossRefGoogle Scholar
  20. 20.
    Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Circulation. 2002;106:2067–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Wong V, McLean M, Boyages S, Cheung NW. CRP levels following acute myocardial infarction: effect of insulin infusion and tight glycemic control. Diabetes Care. 2004;27:2971–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Marfella R, Nappo F, De Angelis L, et al. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care. 2000;23:658–63.PubMedCrossRefGoogle Scholar
  23. 23.
    Wong VW, Mardini M, Cheung NW, Mihailidou A. High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycemia. J Diab Comp. 2011;25:122–8.CrossRefGoogle Scholar
  24. 24.
    Marfella R, D'Amico M, Di Filippo C, et al. Myocardial infarction in diabetic rats: role of hyperglycemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia. 2002;45:1172–81.PubMedCrossRefGoogle Scholar
  25. 25.
    Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.PubMedCrossRefGoogle Scholar
  27. 27.
    Van den Berghe G, Wouters P, Boullon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose vs glycemic control. Crit Care Med. 2003;31:359–66.PubMedCrossRefGoogle Scholar
  28. 28.
    Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.PubMedCrossRefGoogle Scholar
  29. 29.
    Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-center controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2007;33:S189.CrossRefGoogle Scholar
  30. 30.
    Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.PubMedCrossRefGoogle Scholar
  31. 31.
    Arabi YM, Ousama CD, Tamim HM, et al. Intensive vs conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190–7.PubMedCrossRefGoogle Scholar
  32. 32.
    De la Rosa GDC, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalized in a mixed medical and surgical intensive care unit: a randomized clinical trial. Crit Care. 2008;12:R120.CrossRefGoogle Scholar
  33. 33.
    Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303:341–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Finfer S, Chittock DR, Su SY, et al. Intensive vs conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.PubMedCrossRefGoogle Scholar
  35. 35.
    • Finfer S, Liu B, Chittock DR, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108–18. This paper documented the high incidence of hypoglycemia in the NICE-SUGAR Study, and examined the relationship between hypoglycemia and mortality. PubMedCrossRefGoogle Scholar
  36. 36.
    Cheung NW, McLean M, Wong VW. Insulin therapy for myocardial infarction. Expert Opin Pharmacother. 2006;7:2495–503.PubMedCrossRefGoogle Scholar
  37. 37.
    Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;20:57–65.CrossRefGoogle Scholar
  38. 38.
    Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J. 1997;314:1512–5.CrossRefGoogle Scholar
  39. 39.
    Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650–61.PubMedCrossRefGoogle Scholar
  40. 40.
    Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765–70.PubMedCrossRefGoogle Scholar
  41. 41.
    Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397–406.PubMedCrossRefGoogle Scholar
  42. 42.
    • Middleton S, McElduff P, Ward J, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomized controlled trial. Lancet. 2011;378:1699–706. The first and only study where an intervention including glucose control resulted in improved stroke outcomes. PubMedCrossRefGoogle Scholar
  43. 43.
    • Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery). Diabetes Care. 2011;34:256–61. This RCT demonstrated that surgical patients with diabetes who achieve lower blood glucose levels have improved clinical outcomes. PubMedCrossRefGoogle Scholar
  44. 44.
    Griesdale DEG, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821–7.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Ling Y, Li X, Gao X. Intensive vs conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Int Med. 2012;23:564–74.CrossRefGoogle Scholar
  46. 46.
    Murad MH, Coburn JA, Coto-Yglesias F, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:49–58.PubMedCrossRefGoogle Scholar
  47. 47.
    Ooi YC, Dagi TF, Maltenfort M, et al. Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery. 2012;71:692–702.PubMedCrossRefGoogle Scholar
  48. 48.
    Kramer AH, Robers DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Critical Care. 2012;16:R203.PubMedCrossRefGoogle Scholar
  49. 49.
    Bellolio MF, Gilmore RM, Stead LG. Insulin for glycaemic control in acute ischemic stroke. Cochrane Database of Systematic Reviews. 2011;9, CD005346. doi: 10.1002/14651858.CD005346.pub3.PubMedGoogle Scholar
  50. 50.
    Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU. A systematic review and meta-analysis. Chest. 2010;137:544–51.PubMedCrossRefGoogle Scholar
  51. 51.
    Kansagara D, Fu R, Freeman M, et al. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011;154:268–82.PubMedCrossRefGoogle Scholar
  52. 52.
    Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94:3163–70.PubMedCrossRefGoogle Scholar
  53. 53.
    Cheung NW. Glucose control during acute myocardial infarction. Intern Med J. 2008;38:345–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Egi M, Bellomo R, Stachowski E, et al. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc. 2010;85:217–24.PubMedCrossRefGoogle Scholar
  55. 55.
    Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest. 2007;117:868–70.PubMedCentralPubMedCrossRefGoogle Scholar
  56. 56.
    Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients. Diabetes Care. 2010;33:467–72.PubMedCrossRefGoogle Scholar
  57. 57.
    American Diabetes Association: standards of medical care in diabetes – 2013. Diabetes Care. 2013;36(Suppl 1):S11–66.Google Scholar
  58. 58.
    Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modelling of errors in insulin dose. Clin Chem. 2001;47:209–14.PubMedGoogle Scholar
  59. 59.
    • Inoue S, Egi M, Kotani J, et al. Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Critical Care. 2013;17:R48. A systematic review examining the accuracy of glucose measurement methods in the ICU. PubMedCrossRefGoogle Scholar
  60. 60.
    Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001;281:E924–30.PubMedGoogle Scholar
  61. 61.
    Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells. The role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795–804.PubMedCrossRefGoogle Scholar
  62. 62.
    Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57:1349–54.PubMedCrossRefGoogle Scholar
  63. 63.
    Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 hours after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27:1289–97.PubMedCrossRefGoogle Scholar
  64. 64.
    Su G, Mi SH, Tao H, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care. 2013;36:1026–32.PubMedCrossRefGoogle Scholar
  65. 65.
    Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality of critically ill patients. Anesthesiology. 2006;105:244–52.PubMedCrossRefGoogle Scholar
  66. 66.
    Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol. 2009;3:1292–301.PubMedCentralPubMedCrossRefGoogle Scholar
  67. 67.
    Krinsley JS, Preiser JC. Intensive insulin therapy to control hyperglycemia in the critically ill: a look back at the evidence shapes the challenges ahead. Crit Care. 2010;14:330.PubMedCrossRefGoogle Scholar
  68. 68.
    Melbin LG, Malmberg K, Ryden L, et al. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial. Eur Heart J. 2013;34:374–79.CrossRefGoogle Scholar
  69. 69.
    Meyfroidt G, Keenan M, Wang X, et al. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med. 2010;38:1021–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Flower O, Finfer S. Glucose control in critically ill patients. Intern Med J. 2012;42:4–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Krinsley JS. Glycemic control, diabetic status and mortality in a heterogeneous population of critically ill patients before and during the era of tight glycemic control. Semin Thorac Cardiovasc Surg. 2006;18:317–25.PubMedCrossRefGoogle Scholar
  72. 72.
    Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycaemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2000;32:2426–32.CrossRefGoogle Scholar
  74. 74.
    Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the 3 domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care. 2013;17:R37.PubMedCrossRefGoogle Scholar
  75. 75.
    Krinsley JS, Meyfroidt G, Van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the 3 domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care. 2012;15:151–60.PubMedCrossRefGoogle Scholar
  76. 76.
    Wong KYC, Wong VW, Ho JT, et al. High cortisol levels in hyperglycemic myocardial infarct patients signify stress hyperglycemia and predict subsequent normalization of glucose tolerance. Clin Endocrinol. 2010;72:189–95.CrossRefGoogle Scholar
  77. 77.
    Egi M, Bellomo R, Stachowski E, French CJ, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36:2249–55.PubMedCrossRefGoogle Scholar
  78. 78.
    Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013;17:305.PubMedCrossRefGoogle Scholar
  79. 79.
    Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154:260–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Klonoff DC. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. J Diabetes Sci Technol. 2011;5:755–67.PubMedCentralPubMedCrossRefGoogle Scholar
  81. 81.
    Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on inpatient glycemic control. Diabetes Care. 2009;32:1119–31.PubMedCrossRefGoogle Scholar
  82. 82.
    Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guideline on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). Cath Cardiovcasc Intervent. 2009;74:E25–68.CrossRefGoogle Scholar
  83. 83.
    Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16–38.PubMedCrossRefGoogle Scholar
  84. 84.
    Australian Diabetes Society. Australian Diabetes Society guidelines for routine Glucose control in hospital. Available at https://www.diabetessociety.com.au/documents/ADSGuidelinesforRoutineGlucoseControlinHospitalFinal2012_000.pdf. Last accessed June 30 2013.
  85. 85.
    Dellinger RP, Levy LL, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228.PubMedCrossRefGoogle Scholar
  86. 86.
    Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251–76.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Dubbo Specialist Medical CentreDubbo Base HospitalDubboAustralia
  2. 2.Department of Diabetes and EndocrinologyWestmead HospitalWestmeadAustralia

Personalised recommendations